FDA Inspection
Recsei Laboratories, LLCRecsei Laboratories, LLC – FDA Inspection, Jul 2, 2013
Record Details
This FDA Inspection record concerns Recsei Laboratories, LLC, with an inspection on July 2, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Recsei Laboratories, LLC
- Inspection Date
- July 2, 2013
- Product Type
- Drugs
View Company Profile
ID · 7e319368-8d9a-4d3b-802b-3802fb6ad17d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 839092
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
8- 21 CFR 211.87Retest of approved components/containers/closures
- 21 CFR 211.137(a)Expiration date lacking
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.166(a)(2)Stability sample storage conditions described
- 21 CFR 211.166(a)(3)Valid stability test methods
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 212.60(d)Supplies adequately controlled
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Recsei Laboratories, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 7, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 19, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Recsei Laboratories, LLC
- FDA Inspection 700627 - 2010-12-07
- FDA Inspection 584179 - 2009-05-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.